miRNAs Profiling in Parkinson's Disease
Trial
N/A
Completed
March 22, 2023
Handwriting Analysis in Movement Disorders
Trial
N/A
Unknown
March 22, 2023
Non-invasive Assessment of Synaptic Plasticity
Trial
N/A
Unknown
March 22, 2023
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of anle138b in Parkinson's Disease
Trial
Phase 1
Completed
March 21, 2023
Instrumental Assessment of Motor Symptoms by Means of Wearable Sensors in Patients With Parkinson's Disease
Trial
N/A
Unknown
March 21, 2023
Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric Disorders
Trial
N/A
Completed
March 21, 2023
Study of Comprehension and Execution of Medication Prescriptions in Parkinsonian Patients and Healthy Volunteers
Trial
N/A
Completed
March 21, 2023
Physical Therapy and Deep Brain Stimulation in Parkinson Disease
Trial
N/A
Completed
March 21, 2023
Efficacy of a Recreation Therapy Wellness Recovery Program for Individuals With Parkinson's Disease
Trial
N/A
Terminated
March 21, 2023
Sensor-based Assessment and Rehabilitation of Balance in Neurological Diseases
Trial
N/A
Unknown
March 21, 2023
A Phase 3 Study With P2B001 in Subjects With Early Parkinson's
Trial
Phase 3
Completed
March 20, 2023
Cost of Parkinson's Disease in Hong Kong
Trial
N/A
Unknown
March 16, 2023
Rock Steady Boxing: A Community Based In Person Class
Trial
N/A
Unknown
March 16, 2023
Serum Biomarkers in Parkinson's Disease at Different Stages
Trial
N/A
Recruiting
March 14, 2023
Improving Walking With Heel-To-Toe Device
Trial
N/A
Completed
March 14, 2023
Unstructured Eye Tracking as a Diagnostic and Prognostic Biomarker in Parkinsonian Disorders
Trial
N/A
Unknown
March 14, 2023
Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison Study
Trial
Phase 4
Completed
March 13, 2023
Chinese DENOVO PD Registry
Trial
N/A
Recruiting
March 13, 2023
Evaluation of the Frequency and Severity of Sleep Abnormalities in Patients With Parkinson's Disease
Trial
N/A
Unknown
March 9, 2023
Abdominal Binder to Treat Orthostatic Hypotension (OH) in Parkinson's Disease (PD)
Trial
Phase 2
Completed
March 9, 2023